Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07128667

Clinical Features and Long-Term Prognosis in Young Patients With Acute Myocardial Infarction

The incidence of acute myocardial infarction (AMI) in young patients is on the rise, placing a heavy health and economic burden on individuals, families, and society. The clinical phenotype and pathophysiological mechanisms of AMI in this population exhibit significant heterogeneity compared to elderly patients, and existing risk assessment tools have limited applicability in this specific group. The core problem this study aims to address is: how to accurately identify specific risk factors in young AMI patients and build an effective risk prediction model to prevent and optimize clinical diagnosis and treatment.

This study will adopt a prospective cohort design to collect multi-dimensional clinical data from young AMI patients. It will systematically analyze their clinical characteristics, risk factors, and coronary lesion status to comprehensively map the clinical, risk factor, and pathophysiological diversity of young AMI patients. Secondly, it will delve into identifying specific risk factors that influence the onset, progression, and long-term prognosis of young AMI. Thirdly, it will combine machine learning algorithms to develop a risk prediction model for young AMI, performing internal validation in the prospective cohort and external validation in the MIMIC-IV database. Simultaneously, it will explore novel biomarkers associated with disease onset and progression. The key outcomes of this study are to establish a high-quality clinical database of young AMI patients, design a risk prediction model for young AMI based on the study results, and produce high-level academic publications.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 45 years (inclusive of 18 and 45 years);
  • Meeting the diagnostic criteria for acute myocardial infarction (including both ST-elevation myocardial infarction and non-ST-elevation myocardial infarction);
  • Presenting for medical attention within 24 hours of symptom onset;
  • The subject (or their legal representative) is willing and able to sign the informed consent form (for the prospective follow-up portion);
  • Life expectancy greater than 1 year.

Exclusion criteria

  • (1) History of prior old myocardial infarction, severe valvular heart disease, or heart failure; (2) Pregnancy or lactation; (3) Mental disorders or other conditions that prevent cooperation with treatment; (4) Concomitant severe infection, inflammatory or immunological biomarker changes unrelated to AMI, trauma, or recent major surgery.

Treatment and study plan

Primary outcomes

  1. Malignant arrhythmia events

    Time frame: Short-term endpoints (in-hospital and within 30 days post-discharge).Long-term endpoints (12 months post-discharge).

  2. All-cause mortality

    Time frame: Short-term endpoints (in-hospital and within 30 days post-discharge).Long-term endpoints (12 months post-discharge).

  3. Non-fatal myocardial infarction

    Time frame: Short-term endpoints (in-hospital and within 30 days post-discharge).Long-term endpoints (12 months post-discharge).

Study contacts

Contact information is provided by the study sponsor or research team.

Zhengqin Zhai, Dr

CONTACT

[email protected]

+86 18612511571

Sponsors and collaborators

Lead sponsor

China-Japan Friendship Hospital

Other

Registry information

Official study title

A Prospective Cohort Study on Clinical Characteristics, Risk Factors, and Long-Term Outcomes in Young Patients With Acute Myocardial Infarction

Acronym: AMI-Youth

Important dates

Study start
2025
Primary completion
2026
Study completion
2028
First posted
Aug 19, 2025
Registry last updated
Aug 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.